Amarin Corp Plc (AMRN)

[rosemountbomber]

I will welcome others to correct or educate me, but my thought as to an answer to your question is that beyond approval and a thumbs up for reimbursement, the company still needs to launch, market, and educate to gain sales. Just because Vazkepa is written down in some book that it is now being reimbursed for doesn't mean docs automatically start writing scripts for it. Except for New Zealand, there is no advertising for drugs in these other places and it requires some get out the info by the company. That is why it has always basically been understood that Amarin couldn't launch V around the world by itself and needed to be bought out. Heck, I remember way back when, just after Marine approval when Joe Z was touting more suitors than employees. But I think the idea of GIA (or an unreasonable expectation of a selling price) enamored JT to the point that he lost the focus of the primary directive.